The Department of Medicine houses 12 Divisions with broad interests that are of relevance to human disease. Our work extends from basic biomedical research through to the clinic, and is intimately linked to other scientists throughout the Cambridge Biomedical Campus, the UK and the wider internationally community.
The Department of Medicine is one of the largest of the departments in the School of Clinical Medicine, and is located over 5 floors of Addenbrookes’s Hospital, the MRC Laboratory of Molecular Biology, the Addenbrooke’s Centre for Clinical Investigation, the Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID), and the Heart and Lung Research Institute from 2021. Members of the Department also have research groups in the Cambridge Institute of Medical Research, CRUK Cambridge Institute, and the Institute of Metabolic Sciences.
Research is the major focus of the Department, spanning fundamental aspects of biology through work on disease mechanisms to clinical translation. In addition the Department plays a major role in contributing to patient care at Addenbrooke’s and Papworth hospitals. It provides direct medical input into eighteen different speciality areas, with two-thirds of Principal Investigators being clinically active. A number of NHS employees with active research interests are also hosted within the Department, where they hold Associate PI status. The Department is also heavily involved in clinical student education and runs successful MPhil and PhD programmes. It therefore makes a major contribution to service delivery and education as part of Cambridge University Health Partners, and this integration is critical to its focus on improving healthcare throughout the UK and abroad.
Featured News
Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital
The clinical trial – named HEAL-COVID – also aims to cut the number of patients being readmitted to hospital with…
The story behind the UK’s world-leading SARS-CoV-2 genomics capability.
Professor Sharon Peacock explains the story behind the UK’s world-leading SARS-CoV-2 genomics capability.